Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 443

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Urinary incontinence in women

Open access
Aoki, Yoshitaka, Brown, Heidi W., Brubaker, Linda, Cornu, Jean Nicolas, Daly, J. Oliver, Cartwright, Rufus·2017·Nature Reviews Disease Primers
DOI 10.1038/nrdp.2017.42
Open this paper in CoChat — free account

Abstract

Urinary incontinence symptoms are highly prevalent among women, have a substantial effect on health-related quality of life and are associated with considerable personal and societal expenditure. Two main types are described: stress urinary incontinence, in which urine leaks in association with physical exertion, and urgency urinary incontinence, in which urine leaks in association with a sudden compelling desire to void. Women who experience both symptoms are considered as having mixed urinary incontinence. Research has revealed overlapping potential causes of incontinence, including dysfunction of the detrusor muscle or muscles of the pelvic floor, dysfunction of the neural controls of storage and voiding, and perturbation of the local environment within the bladder. A full diagnostic evaluation of urinary incontinence requires a medical history, physical examination, urinalysis, assessment of quality of life and, when initial treatments fail, invasive urodynamics. Interventions can include non-surgical options (such as lifestyle modifications, pelvic floor muscle training and drugs) and surgical options to support the urethra or increase bladder capacity. Future directions in research may increasingly target primary prevention through understanding of environmental and genetic risks for incontinence.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/nrdp.2017.42

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Research works printed but not linked: 184

  1. Haylen, B. T. et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Neurourol. Urodyn. 29, 4–20 (2009). A useful document on the terminology of urinary incontinence that is important for clinical practice and research. · DOI · Paper page
  2. Shakespeare, K., Barradell, V. & Orme, S. Management of urinary incontinence in frail elderly women. Obstet. Gynaecol. Reprod. Med. 21, 281–287 (2011). · DOI
  3. Saarni, S. I. et al. The impact of 29 chronic conditions on health-related quality of life: a general population survey in Finland using 15D and EQ-5D. Qual. Life Res. 15, 1403–1414 (2006). · DOI · Paper page
  4. Subak, L. L. et al. High costs of urinary incontinence among women electing surgery to treat stress incontinence. Obstet. Gynecol. 111, 899–907 (2008). · doi:10.1097/aog.0b013e31816a1e12
  5. Ganz, M. L. et al. Economic costs of overactive bladder in the United States. Urology 75, 526–532.e18 (2010). · doi:10.1016/j.urology.2009.06.096
  6. Irwin, D. E. et al. The economic impact of overactive bladder syndrome in six Western countries. BJU Int. 103, 202–209 (2009). · DOI · Paper page
  7. Hannestad, Y. S., Rortveit, G., Sandvik, H. & Hunskaar, S. A community-based epidemiological survey of female urinary incontinence. J. Clin. Epidemiol. 53, 1150–1157 (2000). · DOI · Paper page
  8. Vaughan, C. P. et al. Impact of obesity on urinary storage symptoms: results from the FINNO Study. J. Urol. 189, 1377–1382 (2013). · DOI
  9. Greer, W. J., Richter, H. E., Bartolucci, A. A. & Burgio, K. L. Obesity and pelvic floor disorders. Obstet. Gynecol. 112, 341–349 (2008). · DOI
  10. Mishra, G. D., Hardy, R., Cardozo, L. & Kuh, D. Body weight through adult life and risk of urinary incontinence in middle-aged women: results from a British prospective cohort. Int. J. Obes. 32, 1415–1422 (2008). · DOI
  11. Agarwal, A. et al. What is the most bothersome lower urinary tract symptom? Individual- and population-level perspectives for both men and women. Eur. Urol. 65, 1211–1217 (2014). · doi:10.1016/j.eururo.2014.01.019
  12. Tikkinen, K. A. O., Leinonen, J. S., Guyatt, G. H., Ebrahim, S. & Järvinen, T. L. N. What is a disease? Perspectives of the public, health professionals and legislators. BMJ Open 2, e001632 (2012). · DOI
  13. Mitteness, L. S. Knowledge and beliefs about urinary incontinence in adulthood and old age. J. Am. Geriatr. Soc. 38, 374–378 (1990). · DOI
  14. Norton, P. A., MacDonald, L. D., Sedgwick, P. M. & Stanton, S. L. Distress and delay associated with urinary incontinence, frequency, and urgency in women. BMJ 297, 1187–1189 (1988). · DOI · Paper page
  15. Helfand, B. T., Evans, R. M. & McVary, K. T. A comparison of the frequencies of medical therapies for overactive bladder in men and women: analysis of more than 7.2 million aging patients. Eur. Urol. 57, 586–591 (2010). · doi:10.1016/j.eururo.2009.12.025
  16. Wu, J. M., Matthews, C. A., Conover, M. M., Pate, V. & Jonsson Funk, M. Lifetime risk of stress urinary incontinence or pelvic organ prolapse surgery. Obstet. Gynecol. 123, 1201–1206 (2014). · DOI · Paper page
  17. Elstad, E. A., Taubenberger, S. P., Botelho, E. M. & Tennstedt, S. L. Beyond incontinence: the stigma of other urinary symptoms. J. Adv. Nurs. 66, 2460–2470 (2010). · DOI
  18. Klovning, A., Sandvik, H. & Hunskaar, S. Web-based survey attracted age-biased sample with more severe illness than paper-based survey. J. Clin. Epidemiol. 62, 1068–1074 (2009). · DOI
  19. Bedretdinova, D., Fritel, X., Panjo, H. & Ringa, V. Prevalence of female urinary incontinence in the general population according to different definitions and study designs. Eur. Urol. 69, 256–264 (2016). · DOI
  20. Minassian, V. A., Drutz, H. P. & Al-Badr, A. Urinary incontinence as a worldwide problem. Int. J. Gynecol. Obstet. 82, 327–338 (2003). · DOI · Paper page
  21. Cerruto, M. A., D’Elia, C., Aloisi, A., Fabrello, M. & Artibani, W. Prevalence, incidence and obstetric factors’ impact on female urinary incontinence in Europe: a systematic review. Urol. Int. 90, 1–9 (2013). · DOI
  22. Irwin, D. E. et al. Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC Study. Eur. Urol. 50, 1306–1315 (2006). · DOI · Paper page
  23. Minassian, V. A., Stewart, W. F. & Wood, G. C. Urinary incontinence in women. Obstet. Gynecol. 111, 324–331 (2008). · DOI · Paper page
  24. Ebbesen, M. H., Hunskaar, S., Rortveit, G. & Hannestad, Y. S. Prevalence, incidence and remission of urinary incontinence in women: longitudinal data from the Norwegian HUNT study (EPINCONT). BMC Urol. 13, 27 (2013). An important epidemiological study of the natural history of incontinence in women. · DOI · Paper page
  25. Zhang, L. et al. A population-based survey of the prevalence, potential risk factors, and symptom-specific bother of lower urinary tract symptoms in adult Chinese women. Eur. Urol. 68, 97–112 (2015). · DOI
  26. Botlero, R., Urquhart, D. M., Davis, S. R. & Bell, R. J. Prevalence and incidence of urinary incontinence in women: review of the literature and investigation of methodological issues. Int. J. Urol. 15, 230–234 (2008). · DOI · Paper page
  27. Thom, D. Variation in estimates of urinary incontinence prevalence in the community: effects of differences in definition, population characteristics, and study type. J. Am. Geriatr. Soc. 46, 473–480 (1998). · DOI · Paper page
  28. Milsom, I. et al. in Incontinence. 5th International Consultation on Incontinence (eds Abrams, P., Cardozo, L., Khoury, S. & Wein, A. ) 15–107 (ICUD-EAU, 2013).
  29. Stewart, W. F. et al. Urinary incontinence incidence: quantitative meta-analysis of factors that explain variation. J. Urol. 191, 996–1002 (2014). · DOI
  30. Wu, J. M., Hundley, A. F., Fulton, R. G. & Myers, E. R. Forecasting the prevalence of pelvic floor disorders in U.S. women: 2010 to 2050. Obstet. Gynecol. 114, 1278–1283 (2009). · DOI · Paper page
  31. Goode, P. S. et al. Population based study of incidence and predictors of urinary incontinence in black and white older adults. J. Urol. 179, 1449–1454 (2008). · DOI
  32. Mitchell, E. S. & Woods, N. F. Correlates of urinary incontinence during the menopausal transition and early postmenopause: observations from the Seattle Midlife Women's Health Study. Climacteric 16, 653–662 (2013). · DOI
  33. Fenner, D. E. et al. Establishing the prevalence of incontinence study: racial differences in women's patterns of urinary incontinence. J. Urol. 179, 1455–1460 (2008). · DOI
  34. Zhu, L. et al. The epidemiological study of women with urinary incontinence and risk factors for stress urinary incontinence in China. Menopause 16, 831–836 (2009). · DOI · Paper page
  35. Ebbesen, M. H., Hannestad, Y. S., Midthjell, K. & Hunskaar, S. Diabetes and urinary incontinence — prevalence data from Norway. Acta Obstet. Gynecol. Scand. 86, 1256–1262 (2007). · DOI
  36. Brown, J. S. et al. Urinary incontinence in older women: who is at risk? Study of Osteoporotic Fractures Research Group. Obstet. Gynecol. 87, 715–721 (1996). · DOI · Paper page
  37. Gomez-Amaya, S. M., Ruggieri, M. R., Arias Serrato, S. A., Massicotte, V. S. & Barbe, M. F. Gross anatomical study of the nerve supply of genitourinary structures in female mongrel hound dogs. Anat. Histol. Embryol. 44, 118–127 (2014). · doi:10.1111/ahe.12116
  38. Hillary, C. J., Osman, N. & Chapple, C. Considerations in the modern management of stress urinary incontinence resulting from intrinsic sphincter deficiency. World J. Urol. 33, 1251–1256 (2015). · doi:10.1007/s00345-015-1599-z
  39. DeLancey, J. O. L. Structural support of the urethra as it relates to stress urinary incontinence: the hammock hypothesis. Am. J. Obstet. Gynecol. 170, 1713–1723 (1994). An explanation of stress urinary incontinence pathology and the hammock hypothesis. · DOI · Paper page
  40. Roosen, A. et al. A refocus on the bladder as the originator of storage lower urinary tract symptoms: a systematic review of the latest literature. Eur. Urol. 56, 810–820 (2009). · doi:10.1016/j.eururo.2009.07.044
  41. Enck, P. et al. Irritable bowel syndrome. Nat. Rev. Dis. Primers 2, 16014 (2016). · DOI · Paper page
  42. Cartwright, R., Afshan, I., Derpapas, A., Vijaya, G. & Khullar, V. Novel biomarkers for overactive bladder. Nat. Rev. Urol. 8, 139–145 (2011). · DOI
  43. de Groat, W. C., Griffiths, D. & Yoshimura, N. in Comprehensive Physiology 327–396 (Wiley-Blackwell, 2014). · DOI · Paper page
  44. Li, M., Sun, Y., Simard, J. M. & Chai, T. C. Increased transient receptor potential vanilloid type 1 (TRPV1) signaling in idiopathic overactive bladder urothelial cells. Neurourol. Urodyn. 30, 606–611 (2011). · doi:10.1002/nau.21045
  45. Reid, G. & Burton, J. P. Urinary incontinence: making sense of the urinary microbiota in clinical urology. Nat. Rev. Urol. 13, 567–568 (2016). An overview of a paradigm shift: the urinary tract is not sterile and bacteria might have important roles in urinary incontinence. · DOI
  46. Hilt, E. E. et al. Urine is not sterile: use of enhanced urine culture techniques to detect resident bacterial flora in the adult female bladder. J. Clin. Microbiol. 52, 871–876 (2013). · DOI · Paper page
  47. Sorrentino, F. et al. Associations between individual lower urinary tract symptoms and bacteriuria in random urine samples in women. Neurourol. Urodyn. 34, 429–433 (2014). · DOI
  48. Walsh, C. A. & Moore, K. H. Overactive bladder in women: does low-count bacteriuria matter? A review. Neurourol. Urodyn. 30, 32–37 (2010). · DOI
  49. Khasriya, R. et al. Spectrum of bacterial colonization associated with urothelial cells from patients with chronic lower urinary tract symptoms. J. Clin. Microbiol. 51, 2054–2062 (2013). · DOI · Paper page
  50. Ravel, J. et al. Vaginal microbiome of reproductive-age women. Proc. Natl Acad. Sci. USA 108, 4680–4687 (2010). · DOI · Paper page
  51. Pearce, M. M. et al. The female urinary microbiome: a comparison of women with and without urgency urinary incontinence. mBio 5, e01283-14 (2014). · DOI · Paper page
  52. Brubaker, L. & Wolfe, A. J. Microbiota in 2016: associating infection and incontinence with the female urinary microbiota. Nat. Rev. Urol. 14, 72–74 (2017). · doi:10.1038/nrurol.2016.262
  53. Abrams, P. et al. in Incontinence. 5th International Consultation on Incontinence (eds Abrams, P., Cardozo, L., Khoury, S. & Wein, A. ) 1895–1956 (ICUD-EAU, 2013).
  54. Martin, J. L., Williams, K. S., Sutton, A. J., Abrams, K. R. & Assassa, R. P. Systematic review and meta-analysis of methods of diagnostic assessment for urinary incontinence. Neurourol. Urodyn. 25, 674–683 (2006). · DOI
  55. Ruby, C. M. et al. The effect of medication use on urinary incontinence in community-dwelling elderly women. J. Am. Geriatr. Soc. 58, 1715–1720 (2010). · DOI
  56. Lucas, M. G. et al. EAU guidelines on assessment and nonsurgical management of urinary incontinence. Eur. Urol. 62, 1130–1142 (2012). · DOI · Paper page
  57. Wagg, A. et al. Urinary incontinence in frail elderly persons: report from the 5th International Consultation on Incontinence. Neurourol. Urodyn. 34, 398–406 (2014). · DOI
  58. Swift, S. E. & Yoon, E. A. Test–retest reliability of the cough stress test in the evaluation of urinary incontinence. Obstet. Gynecol. 94, 99–102 (1999).
  59. Hsu, T. H., Rackley, R. R. & Appell, R. A. The supine stress test: a simple method to detect intrinsic urethral sphincter dysfunction. J. Urol. 162, 460–463 (1999). · doi:10.1016/s0022-5347(05)68589-8
  60. Ghoniem, G. et al. Evaluation and outcome measures in the treatment of female urinary stress incontinence: International Urogynecological Association (IUGA) guidelines for research and clinical practice. Int. Urogynecol. J. 19, 5–33 (2007). An important paper that describes evaluation and outcome measures for the treatment of stress urinary incontinence. · DOI · Paper page
  61. Orejuela, F. J., Shek, K. L. & Dietz, H. P. The time factor in the assessment of prolapse and levator ballooning. Int. Urogynecol. J. 23, 175–178 (2011). · DOI
  62. Bump, R. C. et al. The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction. Am. J. Obstet. Gynecol. 175, 10–17 (1996). · DOI · Paper page
  63. Swift, S. et al. Validation of a simplified technique for using the POPQ pelvic organ prolapse classification system. Int. Urogynecol. J. 17, 615–620 (2006). · DOI · Paper page
  64. Jelovsek, J. E., Maher, C. & Barber, M. D. Pelvic organ prolapse. Lancet 369, 1027–1038 (2007). · DOI · Paper page
  65. Visco, A. G. et al. The role of preoperative urodynamic testing in stress-continent women undergoing sacrocolpopexy: the Colpopexy and Urinary Reduction Efforts (CARE) randomized surgical trial. Int. Urogynecol. J. 19, 607–614 (2008). · DOI · Paper page
  66. Kim, S.-O., Chung, H. S., Hwang, E. C., Oh, K. J. & Kwon, D. Point Aa of the POP-Q system as a predictive value of urethral mobility in women. Int. Urogynecol. J. 22, 687–691 (2010). · DOI
  67. Swift, S., Barnes, D., Herron, A. & Goodnight, W. Test–retest reliability of the cotton swab (Q-tip®) test in the evaluation of the incontinent female. Int. Urogynecol. J. 21, 963–967 (2010). · doi:10.1007/s00192-010-1135-z
  68. Meyer, I., Szychowski, J. M., Illston, J. D., Parden, A. M. & Richter, H. E. Vaginal swab test compared with the urethral Q-tip test for urethral mobility measurement. Obstet. Gynecol. 127, 348–352 (2016). · doi:10.1097/aog.0000000000001243
  69. Schaer, G., Koechli, O., Schuessler, B. & Haller, U. Perineal ultrasound for evaluating the bladder neck in urinary stress incontinence. Obstet. Gynecol. 85, 220–224 (1995). · DOI · Paper page
  70. Troeger, C., Gugger, M., Holzgreve, W. & Wight, E. Correlation of perineal ultrasound and lateral chain urethrocystography in the anatomical evaluation of the bladder neck. Int. Urogynecol. J. Pelvic Floor Dysfunct. 14, 380–384 (2003). · DOI
  71. Richter, H. E. et al. Demographic and clinical predictors of treatment failure one year after midurethral sling surgery. Obstet. Gynecol. 117, 913–921 (2011). · DOI
  72. Smith, A., Bevan, D., Douglas, H. R. & James, D. Management of urinary incontinence in women: summary of updated NICE guidance. BMJ 347, f5170 (2013). A good summary of the current evidence for treatments of urinary incontinence. · doi:10.1136/bmj.f5170
  73. Buchsbaum, G. M., Albushies, D. T. & Guzick, D. S. Utility of urine reagent strip in screening women with incontinence for urinary tract infection. Int. Urogynecol. J. 15, 391–393 (2004). · doi:10.1007/s00192-004-1192-2
  74. Hessdoerfer, E., Jundt, K. & Peschers, U. Is a dipstick test sufficient to exclude urinary tract infection in women with overactive bladder? Int. Urogynecol. J. 22, 229–232 (2010). · DOI
  75. Holm, A. & Aabenhus, R. Urine sampling techniques in symptomatic primary-care patients: a diagnostic accuracy review. BMC Fam. Pract. 17, 72 (2016). · DOI
  76. Cai, T., Koves, B. & Johansen, T. E. B. Asymptomatic bacteriuria, to screen or not to screen — and when to treat? Curr. Opin. Urol. 27, 107–111 (2017). · DOI
  77. Nicolle, L. E. Urinary tract infections in the older adult. Clin. Geriatr. Med. 32, 523–538 (2016). · DOI
  78. Bettez, M. et al. 2012 update: guidelines for adult urinary incontinence collaborative consensus document for the Canadian Urological Association. Can. Urol. Assoc. J. 6, 354–363 (2012). · doi:10.5489/cuaj.12248
  79. Thüroff, J. W. et al. EAU guidelines on urinary incontinence. Eur. Urol. 59, 387–400 (2011). · DOI · Paper page
  80. Saaby, M.-L. & Lose, G. Repeatability of post-void residual urine ≥100 ml in urogynaecologic patients. Int. Urogynecol. J. 23, 207–209 (2012). · DOI
  81. Ashton-Miller, J. A. & DeLancey, J. O. Functional anatomy of the female pelvic floor. Ann. NY Acad. Sci. 1101, 266–296 (2007). · DOI · Paper page
  82. Dietz, H. P. Pelvic floor ultrasound in prolapse: what's in it for the surgeon? Int. Urogynecol. J. 22, 1221–1232 (2011). · DOI
  83. Dietz, H. P., Nazemian, K., Shek, K. L. & Martin, A. Can urodynamic stress incontinence be diagnosed by ultrasound? Int. Urogynecol. J. 24, 1399–1403 (2013). · DOI
  84. Serati, M. et al. Ultrasound measurement of bladder wall thickness in different forms of detrusor overactivity. Int. Urogynecol. J. 21, 1405–1411 (2010). · doi:10.1007/s00192-010-1194-1
  85. Bogusiewicz, M. et al. Both the middle and distal sections of the urethra may be regarded as optimal targets for ‘outside-in’ transobturator tape placement. World J. Urol. 32, 1605–1611 (2014). · doi:10.1007/s00345-014-1261-1
  86. Herderschee, R., Hay-Smith, E. J. C., Herbison, G. P., Roovers, J. P. & Heineman, M. J. Feedback or biofeedback to augment pelvic floor muscle training for urinary incontinence in women. Cochrane Database Syst. Rev. 7, CD009252 (2011).
  87. Versi, E. Videourodynamic diagnosis of occult genuine stress incontinence in patients with anterior vaginal wall relaxation. J. Soc. Gynecol. Investig. 5, 327–330 (1998).
  88. Schäfer, W. et al. Good urodynamic practices: uroflowmetry, filling cystometry, and pressure–flow studies. Neurourol. Urodyn. 21, 261–274 (2002). · DOI · Paper page
  89. Clement, K. D., Lapitan, M. C. M., Omar, M. I. & Glazener, C. M. A. Urodynamic studies for management of urinary incontinence in children and adults. Cochrane Database Syst. Rev. 10, CD003195 (2013).
  90. Digesu, G. A., Khullar, V., Cardozo, L. & Salvatore, S. Overactive bladder symptoms: do we need urodynamics? Neurourol. Urodyn. 22, 105–108 (2003). · DOI · Paper page
  91. Nager, C. W. et al. A randomized trial of urodynamic testing before stress-incontinence surgery. N. Engl. J. Med. 366, 1987–1997 (2012). A seminal RCT that demonstrates that, for women with uncomplicated, demonstrable stress urinary incontinence, preoperative office evaluation alone is not inferior to evaluation with urodynamic testing. · DOI · Paper page
  92. van Leijsen, S. A. L. et al. Can preoperative urodynamic investigation be omitted in women with stress urinary incontinence? A non-inferiority randomized controlled trial. Neurourol. Urodyn. 31, 1118–1123 (2012). · doi:10.1002/nau.22230
  93. Stöhrer, M. et al. EAU guidelines on neurogenic lower urinary tract dysfunction. Eur. Urol. 56, 81–88 (2009). · DOI · Paper page
  94. Bai, S. W. et al. Relationship between stress urinary incontinence and pelvic organ prolapse. Int. Urogynecol. J. 13, 256–260 (2002). · DOI
  95. Burgio, K. L. Update on behavioral and physical therapies for incontinence and overactive bladder: the role of pelvic floor muscle training. Curr. Urol. Rep. 14, 457–464 (2013). · DOI
  96. Fonda, D. & Abrams, P. Cure sometimes, help always — a ‘continence paradigm’ for all ages and conditions. Neurourol. Urodyn. 25, 290–292 (2006). · doi:10.1002/nau.20187
  97. Elkadry, E. A., Kenton, K. S., FitzGerald, M. P., Shott, S. & Brubaker, L. Patient-selected goals: a new perspective on surgical outcome. Am. J. Obstet. Gynecol. 189, 1551–1557 (2003). · DOI · Paper page
  98. Mahajan, S. T., Elkadry, E. A., Kenton, K. S., Shott, S. & Brubaker, L. Patient-centered surgical outcomes: the impact of goal achievement and urge incontinence on patient satisfaction one year after surgery. Am. J. Obstet. Gynecol. 194, 722–728 (2006). · DOI
  99. Vrijens, D. M. J., Spakman, J. I., van Koeveringe, G. A. & Berghmans, B. Patient-reported outcome after treatment of urinary incontinence in a multidisciplinary pelvic care clinic. Int. J. Urol. 22, 1051–1057 (2015). · DOI
  100. Myers, D. L. Female mixed urinary incontinence: a clinical review. JAMA 311, 2007–2014 (2014). · doi:10.1001/jama.2014.4299
  101. Borrie, M. J., Bawden, M., Speechley, M. & Kloseck, M. Interventions led by nurse continence advisers in the management of urinary incontinence: a randomized controlled trial. CMAJ 166, 1267–1273 (2002).
  102. Huang, A. J. Nonsurgical treatments for urinary incontinence in women. JAMA Intern. Med. 173, 1463–1464 (2013). · DOI
  103. Hunskaar, S. A systematic review of overweight and obesity as risk factors and targets for clinical intervention for urinary incontinence in women. Neurourol. Urodyn. 27, 749–757 (2008). · DOI · Paper page
  104. Subak, L. L., Richter, H. E. & Hunskaar, S. Obesity and urinary incontinence: epidemiology and clinical research update. J. Urol. 182, S2–S7 (2009). · DOI · Paper page
  105. Subak, L. L. et al. Weight loss to treat urinary incontinence in overweight and obese women. N. Engl. J. Med. 360, 481–490 (2009). · DOI · Paper page
  106. Burgio, K. L., Richter, H. E., Clements, R. H., Redden, D. T. & Goode, P. S. Changes in urinary and fecal incontinence symptoms with weight loss surgery in morbidly obese women. Obstet. Gynecol. 110, 1034–1040 (2007). · DOI · Paper page
  107. Dumoulin, C., Hay-Smith, J., Habée-Séguin, Mac, G. & Mercier, J. Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women: a short version Cochrane systematic review with meta-analysis. Neurourol. Urodyn. 34, 300–308 (2014). · DOI · Paper page
  108. Sjöström, M. et al. Internet-based treatment of stress urinary incontinence: 1- and 2-year results of a randomized controlled trial with a focus on pelvic floor muscle training. BJU Int. 116, 955–964 (2015). · DOI · Paper page
  109. Sjöström, M., Umefjord, G., Lindholm, L. & Samuelsson, E. Cost-effectiveness of an Internet-based treatment program for stress urinary incontinence. Neurourol. Urodyn. 34, 244–250 (2013). · DOI
  110. Wyman, J. F., Burgio, K. L. & Newman, D. K. Practical aspects of lifestyle modifications and behavioural interventions in the treatment of overactive bladder and urgency urinary incontinence. Int. J. Clin. Pract. 63, 1177–1191 (2009). · DOI · Paper page
  111. Miller, J. M., Sampselle, C., Ashton-Miller, J., Hong, G.-R. S. & DeLancey, J. O. L. Clarification and confirmation of the Knack maneuver: the effect of volitional pelvic floor muscle contraction to preempt expected stress incontinence. Int. Urogynecol. J. Pelvic Floor Dysfunct. 19, 773–782 (2008). · DOI
  112. Dumoulin, C., Hay-Smith, E. J. C. & Mac Habée-Séguin, G. Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women. Cochrane Database Syst. Rev. 5, CD005654 (2014).
  113. Beyar, N. & Groutz, A. Pelvic floor muscle training for female stress urinary incontinence: five years outcomes. Neurourol. Urodyn. 36, 132–135 (2015). · DOI
  114. Glazener, C. M. A. et al. Twelve-year follow-up of conservative management of postnatal urinary and faecal incontinence and prolapse outcomes: randomised controlled trial. BJOG 121, 112–120 (2013). · DOI · Paper page
  115. Richter, H. E. et al. Continence pessary compared with behavioral therapy or combined therapy for stress incontinence. Obstet. Gynecol. 115, 609–617 (2010). · DOI
  116. Morris, A. R. & Moore, K. H. The Contiform incontinence device? Efficacy and patient acceptability. Int. Urogynecol. J. Pelvic Floor Dysfunct. 14, 412–417 (2003). · doi:10.1007/s00192-003-1094-8
  117. Weber, M. A. et al. Local oestrogen for pelvic floor disorders: a systematic review. PLoS ONE 10, e0136265 (2015). · DOI
  118. Cody, J. D., Richardson, K., Moehrer, B., Hextall, A. & Glazener, C. M. A. Oestrogen therapy for urinary incontinence in post-menopausal women. Cochrane Database Syst. Rev. 4, CD001405 (2009).
  119. Novara, G. et al. A systematic review and meta-analysis of randomized controlled trials with antimuscarinic drugs for overactive bladder. Eur. Urol. 54, 740–764 (2008). · DOI · Paper page
  120. Chapple, C. R. et al. The effects of antimuscarinic treatments in overactive bladder: an update of a systematic review and meta-analysis. Eur. Urol. 54, 543–562 (2008). · DOI · Paper page
  121. Kubota, Y. et al. Correlation between improvements in overactive bladder symptom score and health-related quality of life questionnaires in overactive bladder patients treated with an antimuscarinic drug. Neurourol. Urodyn. 30, 1309–1314 (2011). · doi:10.1002/nau.21065
  122. Vouri, S. M., Kebodeaux, C. D., Stranges, P. M. & Teshome, B. F. Adverse events and treatment discontinuations of antimuscarinics for the treatment of overactive bladder in older adults: a systematic review and meta-analysis. Arch. Gerontol. Geriatr. 69, 77–96 (2017). · DOI
  123. Oefelein, M. G. Safety and tolerability profiles of anticholinergic agents used for the treatment of overactive bladder. Drug Saf. 34, 733–754 (2011). · doi:10.2165/11592790-000000000-00000
  124. Kessler, T. M. et al. Adverse event assessment of antimuscarinics for treating overactive bladder: a network meta-analytic approach. PLoS ONE 6, e16718 (2011). A useful meta-analysis for choosing a drug for the treatment of overactive bladder based on tolerability, covering the majority of currently licensed preparations. · DOI
  125. Kim, T. H. & Lee, K.-S. Persistence and compliance with medication management in the treatment of overactive bladder. Investig. Clin. Urol. 57, 84–93 (2016). · DOI
  126. Linnér, L., Schiöler, H., Samuelsson, E., Milsom, I. & Nilsson, F. Low persistence of anticholinergic drug use in Sweden. Eur. J. Clin. Pharmacol. 67, 535–536 (2010). · doi:10.1007/s00228-010-0917-z
  127. Yeaw, J., Benner, J. S., Walt, J. G., Sian, S. & Smith, D. B. Comparing adherence and persistence across 6 chronic medication classes. J. Manag. Care Pharm. 15, 728–740 (2009).
  128. Reynolds, W. S. et al. Comparative effectiveness of anticholinergic therapy for overactive bladder in women: a systematic review and meta-analysis. Obstet. Gynecol. 125, 1423–1432 (2015). · doi:10.1097/aog.0000000000000851
  129. Buser, N., Ivic, S., Kessler, T. M., Kessels, A. G. H. & Bachmann, L. M. Efficacy and adverse events of antimuscarinics for treating overactive bladder: network meta-analyses. Eur. Urol. 62, 1040–1060 (2012). · DOI · Paper page
  130. MacDiarmid, S. et al. Mirabegron as add-on treatment to solifenacin in patients with incontinent overactive bladder and an inadequate response to solifenacin monotherapy. J. Urol. 196, 809–818 (2016). · doi:10.1016/j.juro.2016.03.174
  131. Drake, M. J. et al. Efficacy and safety of mirabegron add-on therapy to solifenacin in incontinent overactive bladder patients with an inadequate response to initial 4-week solifenacin monotherapy: a randomised double-blind multicentre phase 3B study (BESIDE). Eur. Urol. 70, 136–145 (2016). · doi:10.1016/j.eururo.2016.02.030
  132. Canadian Agency for Drugs and Technologies in Health. in Common Drug Reviewhttps://www.ncbi.nlm.nih.gov/books/NBK349284/ (CADTH, 2015).
  133. Maman, K. et al. Comparative efficacy and safety of medical treatments for the management of overactive bladder: a systematic literature review and mixed treatment comparison. Eur. Urol. 65, 755–765 (2014). · DOI · Paper page
  134. Freemantle, N. et al. Comparative assessment of onabotulinumtoxinA and mirabegron for overactive bladder: an indirect treatment comparison. BMJ Open 6, e009122 (2016). · DOI
  135. Pindoria, N. et al. Persistence with mirabegron therapy for overactive bladder: a real life experience. Neurourol. Urodyn. 36, 404–408 (2015). · doi:10.1002/nau.22943
  136. Jost, W. & Marsalek, P. Duloxetine: mechanism of action at the lower urinary tract and Onuf's nucleus. Clin. Auton. Res. 14, 220–227 (2004). · DOI
  137. Li, J. et al. The role of duloxetine in stress urinary incontinence: a systematic review and meta-analysis. Int. Urol. Nephrol. 45, 679–686 (2013). · DOI
  138. Hunskaar, S. & Welle-Nilsen, L. K. The market lifecycle of duloxetine for urinary incontinence in Norway. Acta Obstet. Gynecol. Scand. 89, 217–222 (2010). · doi:10.3109/00016340903508650
  139. Ford, A. A., Rogerson, L., Cody, J. D. & Ogah, J. Mid-urethral sling operations for stress urinary incontinence in women. Cochrane Database Syst. Rev. 7, CD006375 (2015). The most recent Cochrane comparison of mid-urethral slings for stress urinary incontinence.
  140. Latthe, P. M., Singh, P., Foon, R. & Toozs-Hobson, P. Two routes of transobturator tape procedures in stress urinary incontinence: a meta-analysis with direct and indirect comparison of randomized trials. BJU Int. 106, 68–76 (2009). · DOI
  141. Novara, G. et al. Updated systematic review and meta-analysis of the comparative data on colposuspensions, pubovaginal slings, and midurethral tapes in the surgical treatment of female stress urinary incontinence. Eur. Urol. 58, 218–238 (2010). · DOI · Paper page
  142. Rehman, H., Bezerra, C. C., Bruschini, H. & Cody, J. D. Traditional suburethral sling operations for urinary incontinence in women. Cochrane Database Syst. Rev. 1, CD001754 (2011).
  143. Lapitan, M. C. M. & Cody, J. D. Open retropubic colposuspension for urinary incontinence in women. Cochrane Database Syst. Rev. 6, CD002912 (2012).
  144. Parden, A. M. et al. Incontinence outcomes in women undergoing primary and repeat midurethral sling procedures. Obstet. Gynecol. 121, 273–278 (2013). · DOI
  145. Abdel-Fattah, M., Cao, G. & Mostafa, A. Long-term outcomes for transobturator tension-free vaginal tapes in women with urodynamic mixed urinary incontinence. Neurourol. Urodyn. 36, 902–908 (2016). · doi:10.1002/nau.23192
  146. Leong, R. K., de Wachter, S. G. G., Joore, M. A. & van Kerrebroeck, P. E. V. Cost-effectiveness analysis of sacral neuromodulation and botulinum toxin A treatment for patients with idiopathic overactive bladder. BJU Int. 108, 558–564 (2010). · doi:10.1111/j.1464-410x.2010.09905.x
  147. MacDiarmid, S. A. et al. Long-term durability of percutaneous tibial nerve stimulation for the treatment of overactive bladder. J. Urol. 183, 234–240 (2010). · DOI · Paper page
  148. Peters, K. M. et al. Randomized trial of percutaneous tibial nerve stimulation versus extended-release tolterodine: results from the Overactive Bladder Innovative Therapy Trial. J. Urol. 182, 1055–1061 (2009). · DOI · Paper page
  149. Amundsen, C. L. et al. OnabotulinumtoxinA versus sacral neuromodulation on refractory urgency urinary incontinence in women. JAMA 316, 1366–1374 (2016). · doi:10.1001/jama.2016.14617
  150. Visco, A. G. et al. Anticholinergic therapy versus onabotulinumtoxinA for urgency urinary incontinence. N. Engl. J. Med. 367, 1803–1813 (2012). An important RCT that demonstrates the effectiveness of onabotulinumtoxinA for urgency urinary incontinence. · DOI
  151. Bartoli, S., Aguzzi, G. & Tarricone, R. Impact on quality of life of urinary incontinence and overactive bladder: a systematic literature review. Urology 75, 491–500 (2010). · DOI · Paper page
  152. Monz, B. et al. Patient characteristics associated with quality of life in European women seeking treatment for urinary incontinence: results from PURE. Eur. Urol. 51, 1073–1082 (2007). · doi:10.1016/j.eururo.2006.09.022
  153. Haslam, J. Urinary incontinence: why women do not ask for help. Nurs. Times 101, 47–48 (2005).
  154. Temml, C., Haidinger, G., Schmidbauer, J., Schatzl, G. & Madersbacher, S. Urinary incontinence in both sexes: prevalence rates and impact on quality of life and sexual life. Neurourol. Urodyn. 19, 259–271 (2000). · DOI · Paper page
  155. de Vries, H. F., Northington, G. M. & Bogner, H. R. Urinary incontinence (UI) and new psychological distress among community dwelling older adults. Arch. Gerontol. Geriatr. 55, 49–54 (2012). · DOI
  156. Salonia, A. et al. Sexual dysfunction is common in women with lower urinary tract symptoms and urinary incontinence: results of a cross-sectional study. Eur. Urol. 45, 642–648 (2004). · DOI · Paper page
  157. Yip, S.-K. et al. The impact of urodynamic stress incontinence and detrusor overactivity on marital relationship and sexual function. Am. J. Obstet. Gynecol. 188, 1244–1248 (2003). · doi:10.1067/mob.2003.273
  158. Nygaard, I. Idiopathic urgency urinary incontinence. N. Engl. J. Med. 363, 1156–1162 (2010). · doi:10.1056/nejmcp1003849
  159. Gotoh, M. et al. Impact of urinary incontinence on the psychological burden of family caregivers. Neurourol. Urodyn. 28, 492–496 (2009). · doi:10.1002/nau.20675
  160. Bekker, M. D. et al. Sexual experiences of men with incontinent partners. J. Sex. Med. 7, 1877–1882 (2010). · DOI
  161. Nilsson, M., Lalos, O., Lindkvist, H. & Lalos, A. Impact of female urinary incontinence and urgency on women's and their partners’ sexual life. Neurourol. Urodyn. 30, 1276–1280 (2011). · DOI
  162. Kang, Y., Phillips, L. R. & Kim, S.-S. Incontinence quality of life among Korean-American women. Urol. Nurs. 30, 130–136 (2010). · doi:10.7257/1053-816x.2010.30.2.130
  163. Perez, L. M. & Webster, G. D. The history of urodynamics. Neurourol. Urodyn. 11, 1–21 (1992). · doi:10.1002/nau.1930110102
  164. Sheng, W., Zhang, H. & Ruth, K.-H. Could urinary nerve growth factor be a biomarker for overactive bladder? A meta-analysis. Neurourol. Urodyn.http://dx.doi.org/10.1002/nau.23210 (2017). · doi:10.1002/nau.23210
  165. Rachaneni, S. et al. Bladder ultrasonography for diagnosing detrusor overactivity: test accuracy study and economic evaluation. Health Technol. Assess. 20, 1–150 (2016). · DOI
  166. Richter, H. E. et al. Genetic contributions to urgency urinary incontinence in women. J. Urol. 193, 2020–2027 (2015). · DOI
  167. Cartwright, R. et al. Identification of two novel genomic loci associated with stress and urgency urinary incontinence in a genome wide association study. Int. Urogynecol. J. 26, S53–S54 (2015).
  168. Raz, R. & Stamm, W. E. A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections. N. Engl. J. Med. 329, 753–756 (1993). · DOI · Paper page
  169. Brumbaugh, A. R. & Mobley, H. L. T. Preventing urinary tract infection: progress toward an effective Escherichia coli vaccine. Expert Rev. Vaccines 11, 663–676 (2012). · DOI · Paper page
  170. von Gontard, A., Heron, J. & Joinson, C. Family history of nocturnal enuresis and urinary incontinence: results from a large epidemiological study. J. Urol. 185, 2303–2307 (2011). · doi:10.1016/j.juro.2011.02.040
  171. Kuh, D., Cardozo, L. & Hardy, R. Urinary incontinence in middle aged women: childhood enuresis and other lifetime risk factors in a British prospective cohort. J. Epidemiol. Community Health 53, 453–458 (1999). · DOI · Paper page
  172. Wilson, D., Dornan, J., Milsom, I. & Freeman, R. UR-CHOICE: can we provide mothers-to-be with information about the risk of future pelvic floor dysfunction? Int. Urogynecol. J. 25, 1449–1452 (2014). · DOI
  173. Hallock, J. L. & Handa, V. L. The epidemiology of pelvic floor disorders and childbirth. Obstet. Gynecol. Clin. North Am. 43, 1–13 (2016). · DOI · Paper page
  174. Hunskaar, S., Lose, G., Sykes, D. & Voss, S. The prevalence of urinary incontinence in women in four European countries. BJU Int. 93, 324–330 (2004). · DOI · Paper page
  175. Ferroni, M. C. et al. Role of the brain stem in tibial inhibition of the micturition reflex in cats. Am. J. Physiol. Renal Physiol. 309, F242–F250 (2015). · doi:10.1152/ajprenal.00135.2015
  176. Fowler, C. J. & Griffiths, D. J. A decade of functional brain imaging applied to bladder control. Neurourol. Urodyn. 29, 49–55 (2009). · DOI · Paper page
  177. Birder, L. & Andersson, K.-E. Urothelial signaling. Physiol. Rev. 93, 653–680 (2013). · DOI · Paper page
  178. Fatton, B., de Tayrac, R. & Costa, P. Stress urinary incontinence and LUTS in women — effects on sexual function. Nat. Rev. Urol. 11, 565–578 (2014). · DOI
  179. Twiss, C. et al. Validating the Incontinence Symptom Severity Index: a self-assessment instrument for voiding symptom severity in women. J. Urol. 182, 2384–2391 (2009). · doi:10.1016/j.juro.2009.07.025
  180. Shaw, C. et al. Validity and reliability of a questionnaire to measure the impact of lower urinary tract symptoms on quality of life: the Leicester Impact Scale. Neurourol. Urodyn. 23, 229–236 (2004). · doi:10.1002/nau.20017
  181. Abraham, L. et al. Development and validation of a quality-of-life measure for men with nocturia. Urology 63, 481–486 (2004). · DOI · Paper page
  182. Coyne, K. S., Thompson, C. L., Lai, J.-S. & Sexton, C. C. An overactive bladder symptom and health-related quality of life short-form: validation of the OAB-q SF. Neurourol. Urodyn. 34, 255–263 (2015). · DOI · Paper page
  183. Barber, M. D., Kuchibhatla, M. N., Pieper, C. F. & Bump, R. C. Psychometric evaluation of 2 comprehensive condition-specific quality of life instruments for women with pelvic floor disorders. Am. J. Obstet. Gynecol. 185, 1388–1395 (2001). · DOI · Paper page
  184. Brown, J. S. et al. The sensitivity and specificity of a simple test to distinguish between urge and stress urinary incontinence. Ann. Intern. Med. 144, 715–723 (2006). · DOI · Paper page

Cited by

See all 443

Metadata

Authors
Aoki, Y., Brown, H. W., Brubaker, L., Cornu, J. N., Daly, J. O., & Cartwright, R.
Venue
Nature Reviews Disease Primers
Publisher
Springer Science and Business Media LLC
Published
2017-07-06
Volume
3
Issue
1
Pages
17042-17042
ISSN
2056-676X (ISSN-L)
DOI
10.1038/nrdp.2017.42
OpenAlex
W2733089542
Cited by
443
References
8
FWCI
3.35
Type
journal article
Language
en
Update notices
correction (2017-11-16)
Open access
green
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Urinary incontinence in women. https://app.cochat.ai/papers/10.1038/nrdp.2017.42
The paper
Aoki, Y., Brown, H. W., Brubaker, L., Cornu, J. N., Daly, J. O., & Cartwright, R. (2017). Urinary incontinence in women. Nature Reviews Disease Primers. https://doi.org/10.1038/nrdp.2017.42

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.